The survey found: More than 83% said they think Americans are turning to DTC programs for GLP-1s because traditional health care access is too difficult or too expensive
For younger men who might want children in the future, or for those who prefer a more natural approach to hormone optimization, HCG monotherapy presents an option worth discussing with healthcare providers
1,2 Hims & Hers went public in 2021 through a SPAC merger with Oaktree Acquisition Corp., valuing it at almost $2 billion
Genetic testing is available as a $99 add-on after your first month of treatment and informs not only timing but also whether you're a candidate for combination therapy or alternative peptide compounds
GPx activity ( Supplementary Figure 3A ) maintained at the baseline level until 1 week after LPS administration and ended the trial with the maximum value, whereas SOD activity ( Supplementary Figure 3B ) remained stable throughout the experiment
J.MartinezA.SlominskiR.LdemannJ.et al (2012)